On February 3, 2022, Lucy Vereshchagina, PhD, Vice President, Science and Regulatory Advocacy, Pharmaceutical Research and Manufacturers of America (PhRMA), appeared before the House Committee on Energy and Commerce Subcommittee on Health, to present PhRMA's testimony on “FDA USER FEE REAUTHORIZATION: ENSURING SAFE AND EFFECTIVE DRUGS AND BIOLOGICS."